Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
Division of Biostatistics and Bioinformatics, Thomas Jefferson University, Philadelphia, PA, USA.
Ann Vasc Surg. 2024 Dec;109:458-465. doi: 10.1016/j.avsg.2024.07.096. Epub 2024 Aug 7.
Deep hypothermic circulatory arrest (DHCA) in patients undergoing descending thoracic (DTAA) or thoracoabdominal aortic aneurysm (TAAA) repair is associated with increased morbidity and mortality. We present our outcomes after open DTAA and TAAA repair with and without DHCA.
From 1999 to 2022, 81 (38.8%) patients undergoing DTAA or TAAA repair required DHCA because proximal cross-clamping was not feasible or aneurysmal pathology extended into the arch and 128 (61.2%) patients required only distal bypass. Because of intrinsic pathological differences in patients requiring DHCA, confidence intervals (CIs) were used to compare groups in lieu of formal hypothesis tests.
DHCA patients had more chronic dissections (64.2% vs. 43.8%, 95% CI for difference: 6-35%) and higher body mass indices (29.5 ± 6.8 vs. 27.2 ± 6.6, CI: 26-421%). More non-DHCA patients had medial degeneration (9.9% vs. 31.3%, CI: -33 to -7%). There were 10 (12.4%) in-hospital deaths for the DHCA and 10 (7.8%) for the non-DHCA group (CI: -5 to 14%). Survival at 10 years was 52.6% (CI: 42.1-65.7%) for the non-DHCA group and 48.3% (CI: 40.3-57.9%) for the DHCA group. The only meaningful differences in postoperative outcomes were intensive care unit (5.5 days vs. 6 days, CI: 12-410%) and hospital stay (19 days vs. 12 days, CI: 74-470%), which were longer in the DHCA group.
Despite longer intensive care unit and hospital length of stays, selective use of DHCA is safe and effective with comparable morbidity and mortality to non-DHCA in open DTAA and TAAA repair.
在接受降胸主动脉(DTAA)或胸腹主动脉瘤(TAAA)修复的患者中,深度低温循环停止(DHCA)与更高的发病率和死亡率相关。我们报告了在有和没有 DHCA 的情况下进行开放 DTAA 和 TAAA 修复的结果。
从 1999 年到 2022 年,81 名(38.8%)接受 DTAA 或 TAAA 修复的患者需要 DHCA,因为近端阻断不可行或动脉瘤病变延伸到弓部,而 128 名(61.2%)患者仅需要远端旁路。由于需要 DHCA 的患者存在内在的病理差异,因此使用置信区间(CI)来比较组,而不是正式的假设检验。
DHCA 患者的慢性夹层更多(64.2% vs. 43.8%,差异的 95%CI:6-35%),体重指数更高(29.5±6.8 vs. 27.2±6.6,CI:26-421%)。更多的非-DHCA 患者有中膜退变(9.9% vs. 31.3%,CI:-33 至-7%)。DHCA 组有 10 例(12.4%)院内死亡,非-DHCA 组有 10 例(7.8%)(CI:-5 至 14%)。非-DHCA 组 10 年生存率为 52.6%(CI:42.1-65.7%),DHCA 组为 48.3%(CI:40.3-57.9%)。术后结果唯一有意义的差异是重症监护病房(5.5 天 vs. 6 天,CI:12-410%)和住院时间(19 天 vs. 12 天,CI:74-470%),DHCA 组更长。
尽管重症监护病房和住院时间较长,但选择性使用 DHCA 在开放 DTAA 和 TAAA 修复中是安全有效的,其发病率和死亡率与非-DHCA 相当。